SCHOOL model and new targeting strategies

Area of Science:

• Immunology
• Pharmacology
• Molecular Biology

Background:

• Protein-protein interactions are crucial in biological processes and represent key targets for drug development.
• Small molecule inhibitors and peptides offer alternatives to protein therapeutics for targeting these interactions.
• Multichain immune recognition receptors (MIRRs) mediate cell activation in hematopoietic cells.

Purpose of the Study:

• To describe specific protein-protein interactions critical for cell activation mediated by MIRRs, as suggested by the novel SCHOOL model.
• To reveal universal therapeutic targets for immune cell-mediated disorders by understanding MIRR triggering and transmembrane signaling.
• To explore the application of the SCHOOL model in drug design, including viral pathogenesis and platelet signaling.

Main Methods:

• The study proposes the Signaling Chain HOmoOLigomerization (SCHOOL) model to explain MIRR triggering and transmembrane signaling.
• It identifies intrareceptor transmembrane and interreceptor cytoplasmic homointeractions as therapeutic targets.
• The model's principles are applied to diverse immune cell types and viral mechanisms.

Main Results:

• The SCHOOL model elucidates the mechanisms of MIRR triggering and transmembrane signaling.
• It identifies intrareceptor and interreceptor interactions as universal therapeutic targets for immune-mediated disorders.
• The model provides insights into viral immune evasion strategies and has led to new platelet inhibitors.

Conclusions:

• The SCHOOL model offers a unified framework for understanding MIRR signaling across different immune cells.
• Targeting key protein-protein interactions involved in MIRR signaling presents a global therapeutic strategy for immune-mediated diseases.
• The SCHOOL model has significant implications for rational drug design, as demonstrated by its application to platelet signaling and viral pathogenesis.